[{"evidenceId":19259,"evidenceType":"GENE_SUMMARY","shortDesc":null,"desc":"FANCA encodes a component of the Fanconi anemia complementation (FANC) group involved in DNA damage repair. Germline mutations of FANCA are associated with Fanconi anemia and predispose to breast cancer.","id":null,"lastEdit":"2017-04-26","status":null,"gene":{"entrezGeneId":2175,"hugoSymbol":"FANCA","name":"Fanconi anemia complementation group A","oncogene":false,"curatedIsoform":"ENST00000389301","curatedRefSeq":"NM_000135.2","geneAliases":["FANCH","FA-H","FAA","FACA","FA"],"tsg":true},"articles":[]},{"evidenceId":19260,"evidenceType":"GENE_BACKGROUND","shortDesc":null,"desc":"While FANCA is subject to wide variety of mutational types, it has been suggested that there is little prognostic value in the different types as evidenced by no clinical differences in the onset of hematologic disease in patients with a lack of FANCA expression and those which a mutated form of the protein (PMID: 21273304). Cells from Fanconi Anemia (FA) patients and the myeloid leukemia cell line (UoC-M1) show hypersensitivity to DNA cross-linking agents such as diepoxybutane (DEB) and mitomycin C (MMC) when grown and treated with these compounds; diagnostic testing using DEB forms the basis of a gold standard test for FA (PMID: 8374893, PMID: 12637330).","id":null,"lastEdit":"2017-04-26","status":null,"gene":{"entrezGeneId":2175,"hugoSymbol":"FANCA","name":"Fanconi anemia complementation group A","oncogene":false,"curatedIsoform":"ENST00000389301","curatedRefSeq":"NM_000135.2","geneAliases":["FANCH","FA-H","FAA","FACA","FA"],"tsg":true},"articles":[{"pmid":"21273304","title":"Origin, functional role, and clinical impact of Fanconi anemia FANCA mutations.","journal":"Blood","pubDate":"2011 Apr 7","volume":"117","issue":"14","pages":"3759-69","authors":"Castella M et al","elocationId":"doi: 10.1182/blood-2010-08-299917","link":null,"reference":"Castella M et al. Blood. 2011 Apr 7;117(14)3759-69.","abstract":null},{"pmid":"12637330","title":"Acquired FANCA dysfunction and cytogenetic instability in adult acute myelogenous leukemia.","journal":"Blood","pubDate":"2003 Jul 1","volume":"102","issue":"1","pages":"7-16","authors":"Lensch MW et al","elocationId":"","link":null,"reference":"Lensch MW et al. Blood. 2003 Jul 1;102(1)7-16.","abstract":null},{"pmid":"8374893","title":"Fanconi anemia. Chromosome breakage and cell cycle studies.","journal":"Cancer genetics and cytogenetics","pubDate":"1993 Aug","volume":"69","issue":"1","pages":"13-6","authors":"Berger R et al","elocationId":"","link":null,"reference":"Berger R et al. Cancer genetics and cytogenetics. 1993 Aug;69(1)13-6.","abstract":null}]}]